Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK health minister Javid tests positive for COVID-19

Sat, 17th Jul 2021 14:01

* Javid says symptoms are mild, awaiting PCR-confirmation

* Health minister had received two AstraZeneca shots

* Vaccines offer high - but not total - COVID protection
(Adds detail on vaccine effectiveness against Delta)

By Alistair Smout

LONDON, July 17 (Reuters) - British health minister Sajid
Javid on Saturday said he had tested positive for COVID-19, but
added that his symptoms were mild and he was thankful to have
had had two doses of vaccine against the disease.

Javid, who has been health secretary for three weeks, has
backed Prime Minister Boris Johnson's plan to scrap all
remaining legal coronavirus restrictions from Monday, despite a
fresh surge of cases fuelled by the highly transmissible Delta
variant.

"This morning I tested positive for COVID," Javid said in a
tweet, adding he had taken a rapid lateral flow test, and was
awaiting confirmation from a PCR test, which needs processing in
a laboratory.

"I'm waiting for my PCR result, but thankfully I have had my
jabs and symptoms are mild."

Javid tweeted on March 17 that he had received a first shot
of Oxford/AstraZeneca's COVID-19 vaccine, posting a
picture of him getting a second dose on May 16.

Vaccines are not 100% effective at preventing infection, but
fully-vaccinated people are less likely to get seriously ill
with COVID-19 even if they can test positive.

Real-world analysis published by Public Health England has
found that two doses of the AstraZeneca vaccine are 60%
effective against symptomatic disease from the Delta variant and
92% effective against hospitalisation.

Britain is facing a new wave of cases of COVID-19, but
Johnson and Javid claim the vaccine programme has largely broken
the link between COVID-19 cases and mortality, although Johnson
has said that the country should reconcile itself to the
prospect of more deaths from COVID.

Britain has the seventh highest COVID-19 death toll in the
world, and has fully vaccinated two-thirds of adults, although
it is not vaccinating children.

Some scientists have warned that the government's reopening
plans for England are dangerous given the significant number of
people who remain unvaccinated and the fact that vaccines are
not 100% effective.
(Reporting by Alistair Smout; Editing by Catherine Evans and
Christina Fincher)

More News
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.